Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 687

recruiting
3 975
countries
28
conditions
2 109

10 403 trials match your criteria

Arteriosclerosis+1

Not recruiting

Study on the Safety and Effects of INZ-701 for Infants with ENPP1 or ABCC6 Deficiency

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years

Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Porphyria non-acute

Not recruiting

Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years

Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

HIV infection

Not recruiting

Study on Metformin for Reversing Accelerated Aging in People Aged 50+ Living with HIV

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

HIV infection

Not recruiting

Study on the Effects of Doravirine on Liver Health in People Living with HIV with Liver Steatosis or Fibrosis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Study of daily low-dose temozolomide in patients with advanced neuroendocrine tumors (NETs) who are not eligible for standard treatments due to their health condition

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years

Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Study of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years

Cardiogenic shock

Not recruiting

Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid

Cardiac failure+1

Not recruiting

Study on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Vericiguat
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.